hospitalGuid,encounterGuid,patientGuid,notesDEID
a157ccfd7c20009546af7ffaf5bd0a7dbd294c2d518e9e221948e98186170a5e,a1cb4b02b687b76d5e217008d7e8bb41e99912674260e3685743b316634c6096,ea5172254cce3ba3b1257b5a4cb05f2e3673ca5c0bd1058af9dc611f029b04fe,"Subjective:
Patient reports intermittent abdominal pain and occasional bloody stools.
Complains of fatigue and easy bruising.
States that he has been compliant with his aminosalicylic acid regimen.
Objective:
Vital Signs: BP 120/80 mmHg, HR 75 bpm, Temp 98.6ï¿½F, RR 16 breaths/min
Abdominal exam: mild tenderness in the left lower quadrant, no palpable masses.
Blood tests:
Hemoglobin: 10.5 g/dL (low)
White blood cell count: 15,000/mm_ (elevated)
Platelet count: 450,000/mm_ (elevated)
Erythrocyte Sedimentation Rate (ESR): 35 mm/hr (elevated)
Colonoscopy: Presence of inflammatory polyps in the colon.
Bone marrow biopsy: Hypercellular marrow consistent with chronic myeloproliferative disease.
Assessment:
Inflammatory Polyps of the Colon
Chronic Myeloproliferative Disease
Plan:
Inflammatory Polyps of the Colon:
Continue aminosalicylic acid 4000 MG daily.
Schedule a follow-up colonoscopy in 6 months to assess the response to treatment.
Consider adding a short course of steroids if symptoms worsen.
Recommend a diet low in processed foods and high in fiber.
Chronic Myeloproliferative Disease:
Refer to a hematologist for further evaluation and management.
Consider starting hydroxyurea to control elevated white blood cell and platelet counts.
Monitor blood counts every 3 months.
Educate patient on the signs and symptoms of worsening disease, such as increased fatigue, bleeding, or bruising.
General:
Encourage adequate hydration and a balanced diet.
Educate patient on the importance of regular follow-up visits.
Provide information on support groups for patients with chronic illnesses."
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,
,,,